K. Kato

发表

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer

Y. Shimada, T. Oka, Ken Kato, 2008, British Journal of Cancer.

Chemosensitivity of patients with recurrent esophageal cancer receiving perioperative chemotherapy.

Y. Shimada, K. Muro, A. Takashima, 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

H. Ueno, Y. Shimada, K. Muro, 2007, British Journal of Cancer.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

Jun Yu Li, E. Baba, E. Van Cutsem, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of tumor growth rate during preceding treatment on tumor response to nivolumab or irinotecan in advanced gastric cancer

K. Muro, M. Tajika, H. Yasui, 2021, ESMO open.

Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: reliable results following long-term follow-up.

H. Sugita, K. Kojima, T. Kawano, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

FGFR2 gene amplification and clinicopathological features in gastric cancer

K. Matsumoto, I. Oda, K. Nishio, 2012, British Journal of Cancer.

Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy

Y. Shimada, T. Hamaguchi, Y. Horita, 2010, Cancer Chemotherapy and Pharmacology.

LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study

S. Oh, S. Sym, I. Chung, 2020 .

Eribulin in BRAF V600E-mutant metastatic colorectal cancer: case series and potential rationale.

K. Muro, K. Honda, T. Ura, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay

A. Yu, Yasuaki Yamada, J. Nishioka, 2000, Leukemia.

THE TREATMENT WITH TRANILAST, A MAST CELL BLOCKER, FOR IDIOPATHIC OLIGOZOOSPERMIA

K. Kato, N. Honda, T. Taki, 2001, Archives of andrology.

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies

K. Muro, K. Kato, S. Mitani, 2019, Case Reports in Oncology.

Phase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer.

M. Shah, P. Enzinger, Y. Zhu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary hepatoid adenocarcinoma of the uterine cervix

K. Kato, M. Itami, K. Suzuka, 2006, International Journal of Gynecologic Cancer.

Treatment of Oligoasthenozoospermia with Tranilast, a Mast Cell Blocker, After Long-Term Administration

K. Kato, N. Honda, T. Taki, 2002, Archives of andrology.

Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality

K. Kato, K. Suzuka, T. Osaki, 2007, International Journal of Gynecologic Cancer.

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Kyung Won Lee, K. Lee, Yoon-Koo Kang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

E. Baba, E. Van Cutsem, F. Lordick, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer

Y. Shimada, T. Hamaguchi, A. Takashima, 2014, British Journal of Cancer.

Bu ji (hozai) for treatment of postoperative gastric cancer patients.

K. Kato, S. Kameoka, K. Hamano, 1994, The American journal of Chinese medicine.

Prognostic value of tropomyosin-related kinases A, B, and C in gastric cancer

H. Sugita, K. Kojima, K. Sugihara, 2016, Clinical and Translational Oncology.

Phase II study of combination therapy with S-1 and irinotecan in patients with advanced colorectal cancer.

Y. Shimada, K. Muro, T. Hamaguchi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase III, randomized, open-label study to compare the efficacy of tislelizumab versus chemotherapy as second-line therapy for advanced unresectable/metastatic esophageal squamous cell carcinoma (ESCC).

J. Ajani, E. Van Cutsem, V. Paton, 2018, Annals of Oncology.

Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients

K. Stoeber, T. Marafioti, H. Daiko, 2020, Cancer Immunology, Immunotherapy.

Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma.

Y. Hamamoto, H. Daiko, Y. Hosoya, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

M. Azuma, M. Ryu, W. Kang, 2019 .

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis.

H. Katayama, T. Shibata, J. Mizusawa, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Cetilistat (ATL-962), a Novel Pancreatic Lipase Inhibitor, Ameliorates Body Weight Gain and Improves Lipid Profiles in Rats

T. Kato, K. Kato, H. Ogino, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Phase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancer.

H. Ueno, Y. Shimada, K. Muro, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prophylactic administration of epinephrine in oxaliplatin-related hypersensitivity reaction.

Y. Shimada, T. Hamaguchi, K. Tada, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III study of nivolumab (nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Two-years update data.

K. Muro, T. Tamura, W. Kang, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Minimal residual disease by circulating tumor DNA analysis for colorectal cancer patients receiving radical surgery: An initial report from CIRCULATE-Japan.

E. Oki, I. Takemasa, M. Ikeda, 2021 .

Interleukin II activity and nutritional state after administration of traditional chinese medicine for post-operative patients of gastric cancer

K. Kato, 1989 .

Adiopokine levels and the risk of gastric cancer: A case-control study

T. Gotoda, H. Katai, T. Hamaguchi, 2008 .

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis.

T. Shibata, J. Mizusawa, J. Eba, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.